Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan schedules in recurrent platinum-sensitive ovarian cancer
NCT00114166Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jan 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jan 2005; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00114166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114166.